AFDD is back for its third year as the only conference to bring together industry leaders, clinicians and academic experts focused on finding an effective anti-fibrotic treatment. Over 3 days […]

  Translating Emerging RNA Editing Approaches for Therapeutic Applications. As CRISPR genome editing struggles to overcome key specificity and delivery challenges in its pursuit to realize therapeutic applications, the 1st […]

The Dermatology Drug Development Summit series is a unique industry-focused forum dedicated to innovating, accelerating and sharing pharmaceutical best practice on the development and bringing to market of new dermatological […]

The inaugural Gene Therapy Analytical Development Summit will unite large pharma and innovative biotechs to develop robust analytical tools to guarantee the consistency, quality and safety of gene therapy products. Focused specifically […]

Targeting RNA Congress Nearly 100% of all small molecule drugs in the market are designed to target proteins. However, only 2% of the human genome actually codes for proteins, leaving […]

At a time when the previously untapped drug discovery opportunity promised within RNA opens up, the 2nd RNA- Targeted Drug Discovery Summit returns to reunite the leading minds from large […]

Now in its 5th year, the Oncolytic Virotherapy Summit is the industry’s definitive guide to turning viral vehicles into clinically effective therapeutics across oncology indications. With 3 days of in-depth […]

The 3rd Microbiome Movement – Gut-Brain Axis Summit is returning to Boston this December and will unite pioneering industry and academic researchers to establish the mechanistic pathways contributing to neurological disorder manifestation, overcome […]

With the rapid rise of digital technology and shifts within the larger healthcare industry, the need to find new talent that can drive innovation has never been more critical. HR […]

The 8th annual PREDiCT: Tumour Models London Summit will return this December with a new speaker faculty to help you benchmark your oncology model selection strategy and target validation. With […]

SMi are pleased to announce the launch of the Respiratory Drug Delivery conference as part of the newly branded Asthma and COPD series, which will be held in London on […]

EARLY-STAGE INNOVATIONS | ACADEMIA-INDUSTRY COLLABORATIONS | TECHNOLOGY TRANSFER | SEED INVESTMENT With the highest attending rate of TTOs, research institutes and academia together with big pharma, emerging and small biotech, […]

The explosion in cell therapy development companies has fueled a need to develop well-characterized clinical products which has resulted in the call for robust and validated analytical assays now being […]

Assessing the regulatory environment and future of PFS design and development SMi are pleased to present the 12th Annual Pre-Filled Syringes and Injectable Drug Devices conference in London on 15th and 16th January […]

The conference aims to bring together experts of emerging technologies to discover the opportunities with regards to Artificial intelligence, Machine Learning, Internet of Things, Digital therapeutics, eHealth and blockchain. The […]

SPONSORED BY Associates of Cape Cod, bioMérieux, COPAN, METTLER TOLEDO, Microgenetics, Reading Scientific Services Limited, Veltek Associates CHAIRED BY James Drinkwater, Chairman, Pharmaceutical and Healthcare Science Society Olivier Chancel, Sterility and Aseptic Practices Expert, Boehringer Ingelheim […]

The Temperature Control and Logistics forum remains the industries foremost operational and hands on conference to discuss everything logistics, supply chain and temperature controlled for the Pharmaceutical Industry. Our vision […]

The CCP Summit 2020 is the only dedicated community for continuous manufacturing commercialization in Pharma. Four years in the drug development world isn’t long, and the progress made in continuous […]

Exploring the dynamics, legalities and hurdles in a period of transition for Parallel Trade SMi presents Europe's leading 14th annual Parallel Trade conference, taking place in London on the 4th-5th […]

The Smartlab Exchange is an invitation-only meeting bringing together 70 of the most senior lab leaders from across the world, plus a number of hand-selected solution providers for two days […]

Since our past editions we dedicated our focus on the latest developments and addressed various applications of CRISPR as a molecular tool, gene expression, knock-in, genomic screening, along with therapeutic […]

The 5th Annual Biomarker and Companion Diagnostics Conference scheduled to be held on 6th - 7th February 2020 in San Diego, CA would address the gaps between early stage biomarker […]

What are the essentials being missed out on? What is the real role of probiotics strains, prebiotics and symbiotic in influencing a health? How do you standardize microbiome analysis? Witness […]

The Smartlab Exchange is an invitation-only meeting bringing together 70 of the most senior lab leaders from across Europe, plus a number of hand-selected solution providers for two days of […]

Now in it's 12th year, the 2020 Disposable Solutions for Biomanufacturing Forum is the only global forum that focuses on the use of disposable products and single use systems in […]

SMi Group are pleased to present the 11th Annual RNA Therapeutics Conference and Focus Day in London on February 18th - 20th 2020. The field of RNA therapeutics is rapidly […]

CHAIRED BY: Philip Hewitt, UK and Eurotox Registered Toxicologist, Global Head of Early Investigative Toxicology, Merck Healthcare KGaA Stefan Przyborski, Professor of Cell Technology, Durham university Development and application of human organs and tissues […]

With CAR-T therapies on the cusp of achieving global approval, there are still many bottlenecks that are preventing this from becoming the ‘sell-out’ therapy that the field had hoped for. […]

Translating Emerging Antigen Specific Immune Tolerance Approaches for Therapeutic Applications Accelerate the progression of ethical and effective antigen specific immunotherapies through the clinic, optimize the discovery of novel targets and […]

After three decades of trial and error to target the driver of 30% of all diagnosed cancers, scientists are finally making meaningful clinical progression to target the cancer master switch, […]